The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of ...

"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...

Amble Health's website states it is a platform connecting patients to licensed healthcare professionals online, who can ...

Making weight loss injections available to all eligible individuals in the U.K. could yield an economic boost of 4.5 billion ...

Novo Nordisk reduced its starter dose prices through telehealth platforms to encourage patients to wean themselves off compounded copycats.

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down ...

The boss of the drugs giant behind Ozempic has quit after falling behind in the global race to develop weight-loss medication ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.